"Executive Summary: North America Adalimumab Market Size and Share by Application & Industry CAGR Value The expected CAGR of adalimumab market is tend to be around 5.40 % in the mentioned forecast period. The market was valued at USD 16,879.8 million in 2022, and it would grow upto USD 25,709.4 million by 2030.  In the leading North America Adalimumab Market report, industry...